title: Is GPR17 a P2Y/leukotriene receptor? examination of uracil nucleotides, nucleotide sugars, and cysteinyl leukotrienes as agonists of GPR17.
abstract: The orphan receptor GPR17 has been reported to be activated by UDP, UDP-sugars, and cysteinyl leukotrienes, and coupled to intracellular Ca(2+) mobilization and inhibition of cAMP accumulation, but other studies have reported either a different agonist profile or lack of agonist activity altogether. To determine if GPR17 is activated by uracil nucleotides and leukotrienes, the hemagglutinin-tagged receptor was expressed in five different cell lines and the signaling properties of the receptor were investigated. In C6, 1321N1, or Chinese hamster ovary (CHO) cells stably expressing GPR17, UDP, UDP-glucose, UDP-galactose, and cysteinyl leukotriene C4 (LTC4) all failed to promote inhibition of forskolin-stimulated cAMP accumulation, whereas both UDP and UDP-glucose promoted marked inhibition (>80%) of forskolin-stimulated cAMP accumulation in C6 and CHO cells expressing the P2Y14 receptor. Likewise, none of these compounds promoted accumulation of inositol phosphates in COS-7 or human embryonic kidney 293 cells transiently transfected with GPR17 alone or cotransfected with Gαq/i5, which links Gi-coupled receptors to the Gq-regulated phospholipase C (PLC) signaling pathway, or PLCε, which is activated by the Gα12/13 signaling pathway. Moreover, none of these compounds promoted internalization of GPR17 in 1321N1-GPR17 cells. Consistent with previous reports, coexpression experiments of GPR17 with cysteinyl leukotriene receptor 1 (CysLTR1) suggested that GPR17 acts as a negative regulator of CysLTR1. Taken together, these data suggest that UDP, UDP-glucose, UDP-galactose, and LTC4 are not the cognate ligands of GPR17.
authors.affiliation: Department of Pharmacology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
authors.forename: Ai-Dong
authors.initials: AD
authors.lastname: Qi
authors.forename: T Kendall
authors.initials: TK
authors.lastname: Harden
authors.forename: Robert A
authors.initials: RA
authors.lastname: Nicholas
mesh_terms: D000818:Animals; D016466:CHO Cells; D019556:COS Cells; D002522:Chlorocebus aethiops; D006224:Cricetinae; D003412:Cricetulus; D003545:Cysteine / Q000378:metabolism* / Q000494:pharmacology; D057809:HEK293 Cells; D006801:Humans; D015289:Leukotrienes / Q000378:metabolism* / Q000494:pharmacology; D043562:Receptors, G-Protein-Coupled / Q000819:agonists* / Q000378:metabolism*; D058470:Receptors, Purinergic P2Y / Q000378:metabolism*; D014500:Uracil Nucleotides / Q000378:metabolism* / Q000494:pharmacology; D014532:Uridine Diphosphate Glucose / Q000378:metabolism / Q000494:pharmacology
chemical_list: C121670:GPR17 protein, human; D015289:Leukotrienes; D043562:Receptors, G-Protein-Coupled; D058470:Receptors, Purinergic P2Y; D014500:Uracil Nucleotides; C112381:cysteinyl-leukotriene; D003545:Cysteine; D014532:Uridine Diphosphate Glucose
references.citation: Biochem Pharmacol. 2001 Nov 1;62(9):1193-200
references.pmid: 11705452
references.citation: Proc Natl Acad Sci U S A. 2009 Jul 14;106(28):11685-90
references.pmid: 19561298
references.citation: J Biol Chem. 1992 Nov 5;267(31):21995-8
references.pmid: 1331042
references.citation: Biochem Biophys Res Commun. 1996 Feb 6;219(1):105-10
references.pmid: 8619790
references.citation: BMC Bioinformatics. 2008 Jun 04;9:263
references.pmid: 18533035
references.citation: Biochem Biophys Res Commun. 1997 Jul 18;236(2):455-60
references.pmid: 9240460
references.citation: J Biol Chem. 1996 Aug 2;271(31):18363-7
references.pmid: 8702478
references.citation: J Pharmacol Exp Ther. 1993 Dec;267(3):1140-6
references.pmid: 8263774
references.citation: J Biol Chem. 2003 Jul 11;278(28):25600-6
references.pmid: 12724320
references.citation: J Med Chem. 2004 Oct 21;47(22):5393-404
references.pmid: 15481977
references.citation: Biochem Biophys Res Commun. 2008 Jul 11;371(4):707-12
references.pmid: 18466763
references.citation: Biochem Pharmacol. 2005 Dec 19;71(1-2):115-25
references.pmid: 16280122
references.citation: Purinergic Signal. 2013 Sep;9(3):451-62
references.pmid: 23801362
references.citation: EMBO J. 2006 Oct 4;25(19):4615-27
references.pmid: 16990797
references.citation: Pharmacol Rev. 2006 Sep;58(3):281-341
references.pmid: 16968944
references.citation: Am J Physiol Cell Physiol. 2009 Oct;297(4):C1028-40
references.pmid: 19625605
references.citation: Mol Pharmacol. 2003 May;63(5):1190-7
references.pmid: 12695547
references.citation: Nat Genet. 2008 Mar;40(3):329-34
references.pmid: 18297070
references.citation: Purinergic Signal. 2011 Dec;7(4):463-8
references.pmid: 21773766
references.citation: Cell. 2012 Jun 8;149(6):1314-26
references.pmid: 22682251
references.citation: Nature. 2004 May 13;429(6988):188-93
references.pmid: 15141213
references.citation: Nature. 1993 May 20;363(6426):274-6
references.pmid: 8387644
references.citation: Glia. 2013 Jul;61(7):1155-71
references.pmid: 23640798
references.citation: Br J Pharmacol. 1995 Sep;116(1):1619-27
references.pmid: 8564228
references.citation: J Cell Sci. 2005 Dec 1;118(Pt 23):5625-36
references.pmid: 16306225
references.citation: Mol Pharmacol. 2009 Dec;76(6):1341-8
references.pmid: 19759354
references.citation: Nat Neurosci. 2009 Nov;12(11):1398-406
references.pmid: 19838178
references.citation: Biochem Biophys Res Commun. 2007 Nov 23;363(3):861-6
references.pmid: 17905198
references.citation: Mol Pharmacol. 1996 Aug;50(2):258-65
references.pmid: 8700132
references.citation: J Pharmacol Exp Ther. 2011 Aug;338(2):559-67
references.pmid: 21531793
references.citation: J Biol Chem. 1997 May 9;272(19):12583-90
references.pmid: 9139711
references.citation: Mol Pharmacol. 1998 Sep;54(3):541-6
references.pmid: 9730913
references.citation: J Immunol. 2010 Aug 1;185(3):1846-54
references.pmid: 20574000
references.citation: Purinergic Signal. 2004 Dec;1(1):67-74
references.pmid: 18404402
references.citation: Br J Pharmacol. 2010 Mar;159(5):1092-105
references.pmid: 20148890
references.citation: J Biol Chem. 2000 Sep 29;275(39):30531-6
references.pmid: 10851239
references.citation: Biochem Biophys Res Commun. 1997 Jul 9;236(1):106-12
references.pmid: 9223435
references.citation: PLoS One. 2008;3(10):e3579
references.pmid: 18974869
references.citation: Br J Pharmacol. 2001 Jan;132(1):318-26
references.pmid: 11156592
references.citation: J Biol Chem. 2004 May 7;279(19):19790-9
references.pmid: 15001573
references.citation: J Biol Chem. 2002 Mar 8;277(10):7761-5
references.pmid: 11788591
references.citation: Mol Pharmacol. 2006 Jun;69(6):2068-75
references.pmid: 16554409
references.citation: Nature. 1997 Jun 5;387(6633):620-4
references.pmid: 9177352
references.citation: J Biol Chem. 2007 Jun 29;282(26):19042-51
references.pmid: 17472961
references.citation: Biochem Biophys Res Commun. 1997 Jun 27;235(3):717-21
references.pmid: 9207227
references.citation: Mol Pharmacol. 2001 Dec;60(6):1375-82
references.pmid: 11723245